Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.34 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.34 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2257677 | 1.00 | CYP1A2 (0.37) | CYP1A2MAPTCYP2C9CYP2C19TLR8 | |
| SCHEMBL2214680 | 0.85 | CYP1A2 (0.31) | CYP1A2 | |
| SCHEMBL2214195 | 0.85 | UGT2B7 (0.35) | — | |
| SCHEMBL27822818 | 0.82 | MCHR1 (0.40) | MAPTMCHR1 | |
| SCHEMBL637304 | 0.81 | HTT (0.31) | — | |
| SCHEMBL6754650 | 0.81 | — | — | |
| SCHEMBL2456163 | 0.80 | LMNA (0.33) | — | |
| SCHEMBL15412161 | 0.79 | CYP1A2 (0.31) | CYP1A2MAPTCYP2C9CYP2C19 | |
| SCHEMBL3237917 | 0.78 | CA1 (0.30) | — | |
| SCHEMBL64917 | 0.78 | CYP1A2 (0.40) | CYP1A2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1414833-A1 | NOVEL TRANSITION-METAL COMPLEXES AND USE THEREOF IN TRANSITION-METAL CATALYSED REACTIONS | Bayer Chemicals AG (DE) | 2004-05-06 | — | — | EP | disclosed |
| WO-2003011875-A1 | NOVEL TRANSITION-METAL COMPLEXES AND USE THEREOF IN TRANSITION-METAL CATALYSED REACTIONS | BAYER CHEMICALS AG (DE) | 2003-02-13 | — | — | WO | disclosed |